Wockhardt Q4 Results
- BSE: 532300
- NSE: WOCKPHARMA
- ISIN: INE049B01025
- Sector: Biotechnology & Drugs
BSE
1,893.90
-28.70 (-1.49%)
-28.70 (-1.49%)Volume18.75 K
Updated: Tue 21 Jul, 2026 | 15:43:03
NSE
1,896.30-27.10 (-1.41%)
-27.10 (-1.41%)Volume2.97 L
Updated: Tue 21 Jul, 2026 | 15:42:25
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹965.00 Cr.(29.88%)
- Operating Profit₹165.00 Cr.(534.62%)
- Profit After Tax₹166.00 Cr.(NA%)
- Operating Margin17.10%(388.62%)
Note: Comparison is on YoY basis
Quarterly - Wockhardt Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 800.00 | 790.00 | 1.27% | 807.00 | 11.58% |
| Depreciation/ Amortization | 53.00 | 65.00 | -18.46% | 58.00 | 0.00% |
| Operating Income | 165.00 | 98.00 | 68.37% | -,107.00 | 534.62% |
| Net Income | 166.00 | 59.00 | 181.36% | -,169.00 | 0.00% |
| Other Operating Expenses Total | 264.00 | 217.00 | 21.66% | 219.00 | 10.92% |
| Net Income Before Taxes | 189.00 | 67.00 | 182.09% | -,180.00 | 0.00% |
| Total Revenue | 965.00 | 888.00 | 8.67% | 700.00 | 29.88% |
| Selling/ General/ Admin Expenses Total | 187.00 | 181.00 | 3.31% | 157.00 | 12.65% |
| Diluted Normalized EPS | 9.03 | 4.17 | 116.70% | -5.80 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.